Relapsed And Or Refractory Multiple Myeloma Rrmm clinical trials

Explore recruiting relapsed and or refractory multiple myeloma rrmm clinical trials.

Recruiting relapsed and or refractory multiple myeloma rrmm studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed And Or Refractory Multiple Myeloma Rrmm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, Phase 2, open label study evaluating subcutaneous administration of isatuximab in combination with carfilzomib and dexamethasone in adult participants with relapsed and/or refractory multiple myeloma (RRMM)

Greece, Czechia, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, Phase 3, open label study evaluating subcutaneous versus intravenous administration of isatuximab in combination with pomalidomide and dexamethasone in adult patients with relapsed and/or refractory multiple myeloma (RRMM)

France, Italy, Germany, Poland, Czechia, Hungary +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Relapsed And Or Refractory Multiple Myeloma Rrmm trials by city

Relapsed And Or Refractory Multiple Myeloma Rrmm in Toronto Relapsed And Or Refractory Multiple Myeloma Rrmm in Vancouver Relapsed And Or Refractory Multiple Myeloma Rrmm in Montreal Relapsed And Or Refractory Multiple Myeloma Rrmm in Calgary Relapsed And Or Refractory Multiple Myeloma Rrmm in Edmonton Relapsed And Or Refractory Multiple Myeloma Rrmm in Ottawa Relapsed And Or Refractory Multiple Myeloma Rrmm in Winnipeg Relapsed And Or Refractory Multiple Myeloma Rrmm in Quebec City Relapsed And Or Refractory Multiple Myeloma Rrmm in Hamilton Relapsed And Or Refractory Multiple Myeloma Rrmm in Kitchener Relapsed And Or Refractory Multiple Myeloma Rrmm in London Relapsed And Or Refractory Multiple Myeloma Rrmm in Halifax Relapsed And Or Refractory Multiple Myeloma Rrmm in New York Relapsed And Or Refractory Multiple Myeloma Rrmm in Los Angeles Relapsed And Or Refractory Multiple Myeloma Rrmm in Chicago Relapsed And Or Refractory Multiple Myeloma Rrmm in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease